Baculoviruses produce two progeny phenotypes during their replication cycles. The occlusion-derived virus (ODV) is responsible for initiating primary infection in the larval midgut, and the budded virus (BV) phenotype is responsible for the secondary infection. The proteomics of several baculovirus ODVs have been revealed, but so far, no extensive analysis of BV-associated proteins has been conducted. In this study, the protein composition of the BV of Autographa californica nucleopolyhedrovirus (AcMNPV), the type species of baculoviruses, was analyzed by various mass spectrometry (MS) techniques, including liquid chromatographytriple quadrupole linear ion trap (LC-Qtrap), liquid chromatography-quadrupole time of flight (LC-Q-TOF), and matrix-assisted laser desorption ionization-time of flight (MALDI-TOF). SDS-PAGE and MALDI-TOF analyses showed that the three most abundant proteins of the AcMNPV BV were GP64, VP39, and P6.9. A total of 34 viral proteins associated with the AcMNPV BV were identified by the indicated methods. Thirteen of these proteins, PP31, AC58/59, AC66, IAP-2, AC73, AC74, AC114, AC124, chitinase, polyhedron envelope protein (PEP), AC132, ODV-E18, and ODV-E56, were identified for the first time to be BV-associated proteins. Western blot analyses showed that ODV-E18 and ODV-E25, which were previously thought to be ODV-specific proteins, were also present in the envelop fraction of BV. In addition, 11 cellular proteins were found to be associated with the AcMNPV BV by both LC-Qtrap and LC-Q-TOF analyses. Interestingly, seven of these proteins were also identified in other enveloped viruses, suggesting that many enveloped viruses may commonly utilize certain conserved cellular pathways.During the baculovirus infection cycle, two progeny virion phenotypes are produced, the budded virus (BV) and the occlusion-derived virus (ODV). The two phenotypes are genotypically identical, but each has characteristic structural components to accommodate its respective functions (37). ODVs are responsible for initiating primary infections in the midgut epithelial cells of susceptible hosts, while BVs are responsible for spreading the virus among cells and tissues in the host (48). At the early stage of the infection, the nucleocapsids are transported through the nuclear membranes and migrate across the cytosol to the cell membrane, where the virus buds out (BV). BVs acquire an envelope of virus-encoded proteins as they bud out of the cell membrane (50). In the late stages of the infection, the nucleocapsids within the nucleus are enveloped with a lipid bilayer that resembles, but is not identical to, the inner nuclear membrane (8, 37). Therefore, it is generally believed that the BV and ODV share the same components of the nucleocapsid but differ in their envelopes. However, detailed structures of the BV and ODV have not been elucidated totally.The availability of genome sequences has facilitated proteomic analyses of baculoviruses, especially by mass spectrometry (MS)-based techniques. Since Braunagel et al. fir...
The replication of lepidopteran baculoviruses is characterized by the production of two progeny phenotypes: the occlusion-derived virus (ODV), which establishes infection in midgut cells, and the budded virus (BV), which disseminates infection to different tissues within a susceptible host. To understand the structural, and hence functional, differences between BV and ODV, we employed multiple proteomic methods to reveal the protein compositions and posttranslational modifications of the two phenotypes of Helicoverpa armigera nucleopolyhedrovirus. In addition, Western blotting and quantitative mass spectrometry were used to identify the localization of proteins in the envelope or nucleocapsid fractions. Comparative protein portfolios of BV and ODV showing the distribution of 54 proteins, encompassing the 21 proteins shared by BV and ODV, the 12 BV-specific proteins, and the 21 ODV-specific proteins, were obtained. Among the 11 ODV-specific envelope proteins, 8 either are essential for or contribute to oral infection. Twenty-three phosphorylated and 6 N-glycosylated viral proteins were also identified. While the proteins that are shared by the two phenotypes appear to be important for nucleocapsid assembly and trafficking, the structural and functional differences between the two phenotypes are evidently characterized by the envelope proteins and posttranslational modifications. This comparative proteomics study provides new insight into how BV and ODV are formed and why they function differently. Baculoviruses are insect-specific pathogens containing large circular double-stranded DNA genomes. Over millions of years of interdependence between viruses and their natural insect hosts, both have undergone a coevolution, such that lepidopteran baculoviruses have developed a unique biphasic replication cycle that generates two progeny phenotypes, the budded virus (BV) and the occlusion-derived virus (ODV). ODVs are embedded in occlusion bodies (OBs) that offer the virions a certain amount of protection against environmental degradation. Once ingested by a susceptible insect, ODVs are released from OBs within the larval midgut and initiate oral infection. After infecting midgut epithelial cells, BVs are synthesized and released to disseminate systemic infection of different tissues within the larval host. The two phenotypes have been used in a wide range of applications. Due to their expandable genome and the presence of very strong promoters, BVs have been established as successful vectors for the expression of thousands of proteins and have also been studied as potential vectors for gene therapy (1). The OBs of certain baculoviruses have been widely used in agriculture and forestry as viable alternatives to chemical insecticides in insect pest control (2).The broad applications of baculoviruses provide a strong rationale for identifying the proteins associated with both phenotypes and for understanding their roles in baculovirus infection. While previous proteomic studies have elucidated the protein compositions of a...
Synthetic viruses provide a powerful platform to delve deeper into the nature and function of viruses as well as to engineer viruses with novel properties. So far, most synthetic viruses have been RNA viruses (<30 kb) and small DNA viruses, such as bacteriophage phiX174. Baculoviruses contain a large circular dsDNA genome of 80-180 kb and have been used as biocontrol agents and protein expression vectors. Here, we report on the first synthesis of a baculovirus based on the type species Autographa californica nucleopolyhedrovirus, AcMNPV, by a combination of PCR and transformation-associated recombination in yeast. The synthetic genome, designated AcMNPV-WIV-Syn1, is 145 299 bp comprising the complete genome of AcMNPV except for the hr4a locus that was replaced with an ∼11.5 kb cassette of bacterial and yeast artificial chromosomal elements and an egfp gene. Sf9 insect cells were transfected with AcMNPV-WIV-Syn1 DNA and progeny virus was examined by electron microscopy, and assayed in one-step growth curves and oral infectivity. The results conclusively showed that the rescued virus AcMNPV-WIV-Syn1 had structural and biological properties comparable to the parental virus. We validated a proof of concept that a bona fide baculovirus can be synthesized. The new platform allows manipulation at any or multiple loci and will facilitate future studies such as identifying the minimal baculovirus genome and construction of better expression vectors. This is the largest DNA virus synthesized so far, and its success is likely to be the impetus to stimulate the fields of other large DNA viruses such as herpesviruses and poxviruses.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.